Global and regional burden of colorectal cancer potentially related to Helicobacter pylori exposure: a risk attribution modelling study.

Key Takeaways for GI Nurses

• This modelling study adds to a growing body of evidence linking H. pylori exposure to colorectal cancer (CRC) risk, suggesting the relationship extends beyond its well-established role in gastric disease—information relevant when educating patients about GI cancer risk factors.
• Because the association varies by region, diagnostic method, and eradication status, nurses should recognize that a patient's H. pylori history (including whether it was successfully treated) may carry implications beyond peptic ulcer disease and gastric cancer risk.
• If future studies validate H. pylori eradication as an adjunct CRC prevention strategy, endoscopy nurses may see increased emphasis on test-and-treat protocols, particularly in high-prevalence, resource-limited settings, and should stay alert to evolving screening/eradication guidelines.
• This research reinforces the importance of thorough patient history-taking during endoscopy visits—documenting prior H. pylori infection and treatment status may become more clinically relevant as risk-stratification models evolve.

Clinical Relevance

For GI and endoscopy nurses, this study represents an important evolution in how we conceptualize H. pylori's clinical footprint. Traditionally, nursing education and patient counseling around H. pylori have centered almost exclusively on its role in gastritis, peptic ulcer disease, and gastric cancer. This risk-attribution modelling study, using global data from GLOBOCAN alongside systematic review and meta-analysis findings, introduces the possibility that H. pylori exposure contributes to a measurable proportion of the global CRC burden. While the authors themselves note the findings remain controversial and mechanistic pathways are still being elucidated, nurses should be aware that this is an active and expanding area of research with potential downstream effects on screening, patient education, and prevention strategies.

From a practical standpoint, this has implications for how endoscopy units approach combined upper and lower GI risk assessment. Patients undergoing colonoscopy who have a known history of H. pylori infection—whether previously eradicated or untreated—may warrant more nuanced risk conversations, particularly in regions or populations with high H. pylori prevalence and limited healthcare resources, as highlighted in the study. Nurses conducting pre-procedure assessments and health histories are often the first point of contact for gathering this information, and increased awareness of this potential CRC link strengthens the case for consistently documenting H. pylori status, including diagnostic method and eradication history, as part of comprehensive GI risk profiles.

On a broader professional development level, this study signals a shift toward integrated GI cancer prevention thinking, where infection control and cancer screening are viewed as interconnected rather than siloed by organ system. Endoscopy nurses involved in patient education, quality improvement initiatives, or research liaison roles should monitor how this evidence evolves, particularly regarding whether professional societies begin incorporating H. pylori eradication status into CRC risk stratification tools or screening interval recommendations. Staying informed positions nursing staff to provide accurate, current patient counseling and to support unit-level protocol updates as guidelines mature.

Bottom Line

This modelling study suggests H. pylori exposure may contribute to a portion of the global CRC burden, particularly in high-prevalence, resource-limited settings—an emerging connection that GI nurses should watch closely, as it may eventually influence patient risk assessment, screening protocols, and the clinical relevance of documenting H. pylori infection and eradication history during endoscopic care.